AMRN's logo.
Ticker Symbol: AMRN

Amarin Corp - ADR

$4.11 - 01-11-2024 4 p.m. ET

Exchange: NASDAQ Country: Ireland Currency: USD Asset Type: ADR CIK:0000897448

Company Profile

amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. vascepa® (icosapent ethyl) is amarin's first fda approved product and is available in the united states by prescription. for more information about vascepa visit www.vascepa.com.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
CEO: John Thero
Tags:
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.75
Change: $0.01 ( 2.35%)
Days Range: $0.72 - $0.78
Beta: 1.75
52wk. High: $2.23
52wk. Low: $0.70
Ytd. Change -35.27%
50 Day Moving Average: $0.89
200 Day Moving Average: $1.13
Shares Outstanding: 98801982

Valuation

Market Cap: 7.5B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A